Se ha denunciado esta presentación.
Utilizamos tu perfil de LinkedIn y tus datos de actividad para personalizar los anuncios y mostrarte publicidad más relevante. Puedes cambiar tus preferencias de publicidad en cualquier momento.
New Developments in PDMPs:
California, Colorado and Minnesota
Presenters:
• Mark R. O’Neill, RPh, Program Manager, Colorad...
Disclosures
• Barbara A. Carter; Tina Farales; Mark R. O’Neill, RPh;
and John L. Eadie have disclosed no relevant, real, o...
Disclosures
• All planners/managers hereby state that they or their
spouse/life partner do not have any financial
relation...
Learning Objectives
1. Express the value of PDMPs as healthcare
tools.
2. Describe PDMP enhancements that improve
data int...
New Developments in PDMPs:
Colorado
Mark R. O’Neill, RPh
Program Manager
Colorado Prescription Drug
Monitoring Program
Focus on Value: A map of Colorado’s rising drug-
related deaths between 2002 and 2014.
Representation of the need for PDMP...
Colorado Drug Overdose Death Rate 2002
“Colorado Drug Death Rate Tops U.S. Average,” Colorado Health Institute, Feb. 2016
Colorado Drug Overdose Death Rate 2014
“Colorado Drug Death Rate Tops U.S. Average,” Colorado Health Institute, Feb. 2016
Colorado PDMP: An overview
 Began 2007. 6 prescribing Boards /
Pharmacy. 2 person staff.
 3rd Party vendor. ~ $175,000 /...
Enhancements: PDMP as a Healthcare Tool
 Legislative Update 2014
 Mandatory registration (not mandatory use) of all DEA
...
Prescription Trends 2014 - 2015
722,964
601,895 585,587
420,108
521,806
450,984
467,922
402,576
400,676
306,348
358,041
32...
Tackling Doctor Shopping - Push Notices
 Obtaining controlled substances from multiple sources in
potentially dangerous q...
Streamlined Retrieval of Data
 Automated Access:
 Single log-on access to patients’ PDMP files
 Inclusion of “Rxcheck”
...
Streamlined Retrieval of Data
 Integration of Electronic Health Records through the
Harold Rogers PDMP Grant for Practiti...
Colorado: Outreach and Education
 Outreach to Colorado – Speakers Bureau offers ongoing
PDMP information.
 Consortium fo...
New Developments in PDMPs:
Minnesota
Barbara A. Carter
PMP Manager
Minnesota Board of Pharmacy
Disclosure Statement
• Barbara A. Carter, has disclosed no relevant,
real or apparent personal or professional
financial r...
Learning Objectives
• Express the value of PDMPs as healthcare
tools.
• Describe PDMP enhancements that improve
data integ...
DATA REPORTING & DATA INTEGRITY:
THE PATH TO IMPROVEMENT
Barbara A Carter, PMP Manager, Minnesota Board of Pharmacy
Identifying the Issues
• Compliance in Reporting
– Are all dispensers reporting?
– How often are they reporting?
• Data Qu...
Facts and Figures
2010
• 1,700 licensed
pharmacies
• 6.6M prescription records
(CS II-IV)
2015
• 2,000 licensed
pharmacies...
Are all dispensers reporting?
• Honor System
– Unmet Expectations
• Unique Pharmacy Identifier
– Pharmacy DEA#
• Match wit...
How often are they reporting?
• Daily reporting required
– By procedure not statute
• Inadequate Reporting
– Definition
• ...
DATA QUALITY
• Who uploads the data?
– Pharmacy staff
– Corporate office
– External vendor
• How are errors communicated a...
Errors impacting end user
• Minor
– Days supply invalid (>180 days)
– Refill code is not a #
• Serious
– Invalid prescribe...
Current initiative
• Blast communication-2 months in advance
– Uploader and PIC
• Error correction within 7 days receipt o...
Determining Compliance
• Errors resolved within 7 days
• Outstanding errors
– Phone call to Pharmacist in Charge (PIC)
• S...
Outcomes
• Compliance in reporting improved
• Frequency of reporting improved
• Improvement in data quality
• Relationship...
Lessons Learned
• Communication is Critical
– PMP and Dispenser
– Dispenser and their Vendor
• Start Out Small
• Hidden Is...
Next Steps
• Recognize “gold star” performance
• Update contact lists
• Update error report communication
preference
• Cre...
THANK YOU
New Developments in PDMPs
California’s CURES 2.0
Mike Small has disclosed no relevant, real or
apparent personal or professional financial
relationships with proprietary e...
New Developments in PDMPs
California’s CURES 2.0
Learning Objective:
Identify the features and benefits of California’s up...
California Health and Safety Code section § 11165. (a)
To assist health care practitioners in their efforts to ensure
appr...
The Iatrogenically Addicted Patient and the
Doctor Shopper
~
Information Delivery
~
Support the Public Health Sector
~
The...
Automated Registration
California clinical users are provided a fully automated
registration process.
Delegation Authority...
Peer-to-Peer Communication
Prescribers and dispensers can instigate alert messages to fellow
doctors and pharmacists about...
CURES 2.0 systematically de-duplicates and de-identifies
county and statewide data sets for County Health Officers and
res...
1. For Each Individual Prescriber, a List of That Prescriber's Rx
Recipients Who are Currently Prescribed More than 100 Mo...
1 Total Number of Prescriptions for Opioid Drugs by Month, by
State, County and Zip Code
2 Total Number of Prescriptions f...
8 Median Number of Opioid Pills Per Prescribed by Calendar Year, by
State, County and Zip Code
9 Number of Patients Receiv...
13 Number of Patients, by Month, Prescribed Both Opioids and
Benzodiasepine, by State, County and Zip Code
14 Number of Pa...
18 Morphine Milligram and Morphine Kilogram Equivalents Prescribed by
Calendar Year, by State, County and Zip Code for: Ox...
21 Total Number of Prescriptions for all Schedule II Drugs by Month, by
State, County and Zip Code
22 Total Number of Pres...
27 Median Number of Pills Per Prescription for Schedules II, III, and IV
Drugs by Month, by State, County and Zip Code
28 ...
33 Number of Prescriber and Dispenser Registrants, by Month, by
State, County and Zip Code
34 Number of Prescriber and Dis...
38 Number of Patients with Same Prescription Drug from 3 or More
Prescribers, by Calendar Year, by State, County and Zip C...
44 Numbers of Prescribers Prescribing Opioids and Benzodiazepines
Concurrently to a Patient, by Year, by State, County, an...
ASAP DATABASE
ENTITY
RESOLUTION
ANOMALY
DETECTION
DE-
IDENTIFIED
DATA
REPORTING
ALERT
GENERATION
ENTITY RESOLUTION
John Doe
01/01/70
456 HARRISON AVE
CARY, NC 27513John Doe
01/01/70
123 HARRISON AVE
CARY, NC 27513
John ...
PATIENT SCENARIOS
1. Rx Recipients Who are Currently Prescribed More than 100
Morphine Milligram Equivalency Per Day
2. Rx...
ENTITY RESOLUTION & SCENARIOS
TIME
30 MME80 MME110 MME110 MME + BENZO
OPIOID
OPIOID
OPIOID
BENZO
ALERTS
• Patient Name
• Patient DOB
• Patient Address
• Patient City
• Patient Zip Code
• # of Anomalous
Scenarios
• Trigg...
DE-IDENTIFIED DATA
 Anonymized Patient ID
 Anonymized Prescriber ID
 Anonymized Pharmacy ID
 Patient Birth Year
 Pati...
Questions?
Thank You!
New Developments in PDMPs:
California, Colorado and Minnesota
Presenters:
• Mark R. O’Neill, RPh, Program Manager, Colorad...
Rx16 pdmp tues_200_1_o_neill_2carter_3small_armagan
Rx16 pdmp tues_200_1_o_neill_2carter_3small_armagan
Rx16 pdmp tues_200_1_o_neill_2carter_3small_armagan
Rx16 pdmp tues_200_1_o_neill_2carter_3small_armagan
Rx16 pdmp tues_200_1_o_neill_2carter_3small_armagan
Próxima SlideShare
Cargando en…5
×

Rx16 pdmp tues_200_1_o_neill_2carter_3small_armagan

554 visualizaciones

Publicado el

New Developments in PDMPs: California, Colorado and Minnesota

Publicado en: Salud y medicina
  • Sé el primero en comentar

  • Sé el primero en recomendar esto

Rx16 pdmp tues_200_1_o_neill_2carter_3small_armagan

  1. 1. New Developments in PDMPs: California, Colorado and Minnesota Presenters: • Mark R. O’Neill, RPh, Program Manager, Colorado Prescription Drug Monitoring Program • Barbara A. Carter, PMP Manager, Minnesota Board of Pharmacy, Prescription Monitoring Program • Tina Farales, Department of Justice Administrator, Prescription Drug Monitoring Program, California Department of Justice • Artin Armagan, PhD, Manager, Advanced Analytics Lab, SAS Institute PDMP Track Moderator: John L. Eadie, Coordinator, Public Health and Prescription Drug Monitoring Program Project, National Emerging Threat Initiative, National HIDTA Assistance Center, and Member, Rx and Heroin Summit National Advisory Board
  2. 2. Disclosures • Barbara A. Carter; Tina Farales; Mark R. O’Neill, RPh; and John L. Eadie have disclosed no relevant, real, or apparent personal or professional financial relationships with proprietary entities that produce healthcare goods and services. • Artin Armagan, PhD – Ownership interest: Walmart (spouse)
  3. 3. Disclosures • All planners/managers hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months. • The following planners/managers have the following to disclose: – John J. Dreyzehner, MD, MPH, FACOEM – Ownership interest: Starfish Health (spouse) – Robert DuPont – Employment: Bensinger, DuPont & Associates-Prescription Drug Research Center
  4. 4. Learning Objectives 1. Express the value of PDMPs as healthcare tools. 2. Describe PDMP enhancements that improve data integrity and streamline retrieval and viewing of PDMP searches and reports. 3. Identify the features and benefits of California’s upgraded PDMP, CURES 2.0. 4. Provide accurate and appropriate counsel as part of the treatment team.
  5. 5. New Developments in PDMPs: Colorado Mark R. O’Neill, RPh Program Manager Colorado Prescription Drug Monitoring Program
  6. 6. Focus on Value: A map of Colorado’s rising drug- related deaths between 2002 and 2014. Representation of the need for PDMP programs in the United States.
  7. 7. Colorado Drug Overdose Death Rate 2002 “Colorado Drug Death Rate Tops U.S. Average,” Colorado Health Institute, Feb. 2016
  8. 8. Colorado Drug Overdose Death Rate 2014 “Colorado Drug Death Rate Tops U.S. Average,” Colorado Health Institute, Feb. 2016
  9. 9. Colorado PDMP: An overview  Began 2007. 6 prescribing Boards / Pharmacy. 2 person staff.  3rd Party vendor. ~ $175,000 / year. Funded by prescriber fees.  Colorado Population: 5.5 million  Over 2.6 million patient specific queries in 2015
  10. 10. Enhancements: PDMP as a Healthcare Tool  Legislative Update 2014  Mandatory registration (not mandatory use) of all DEA registered prescribers  Daily reporting by pharmacies to increase reliability and trust of data  Delegated authority for increased use and access for prescribers and pharmacists – up to 3 trained delegates  Access granted to Colorado Department of Public Health and Environment
  11. 11. Prescription Trends 2014 - 2015 722,964 601,895 585,587 420,108 521,806 450,984 467,922 402,576 400,676 306,348 358,041 329,191300,000 400,000 500,000 600,000 700,000 Prescriptions Dispensed Patients recieving prescriptions
  12. 12. Tackling Doctor Shopping - Push Notices  Obtaining controlled substances from multiple sources in potentially dangerous quantities.  Prescribers and pharmacists can use the PDMP to stop “doctor shopping.”  Push Notice letters are sent out to prescribers and pharmacies monthly.  Push Notices are often a “reality check” for prescribers and pharmacists
  13. 13. Streamlined Retrieval of Data  Automated Access:  Single log-on access to patients’ PDMP files  Inclusion of “Rxcheck”  Allows for efficient, reliable and secure access.  Currently used at two practice sites in Colorado: one major chain pharmacy and one federal facility.
  14. 14. Streamlined Retrieval of Data  Integration of Electronic Health Records through the Harold Rogers PDMP Grant for Practitioner and Research Partnerships  5 major Emergency Departments at Colorado hospitals
  15. 15. Colorado: Outreach and Education  Outreach to Colorado – Speakers Bureau offers ongoing PDMP information.  Consortium for the Prevention of Prescription Drug Abuse: Created as “Task Force” for continued improvement of PDMP.  New PDMP dedicated website  Training webinars  YouTube videos  Production of PDMP brochure
  16. 16. New Developments in PDMPs: Minnesota Barbara A. Carter PMP Manager Minnesota Board of Pharmacy
  17. 17. Disclosure Statement • Barbara A. Carter, has disclosed no relevant, real or apparent personal or professional financial relationships with proprietary entities that produce health care good and services.
  18. 18. Learning Objectives • Express the value of PDMPs as healthcare tools. • Describe PDMP enhancements that improve data integrity and streamline retrieval and viewing of PDMP searches and reports. • Identify the features and benefits of California’s upgraded PDMP, CURES 2.0. • Provide accurate and appropriate counsel as part of the treatment team.
  19. 19. DATA REPORTING & DATA INTEGRITY: THE PATH TO IMPROVEMENT Barbara A Carter, PMP Manager, Minnesota Board of Pharmacy
  20. 20. Identifying the Issues • Compliance in Reporting – Are all dispensers reporting? – How often are they reporting? • Data Quality – How accurate is the data? – Are there missing records?
  21. 21. Facts and Figures 2010 • 1,700 licensed pharmacies • 6.6M prescription records (CS II-IV) 2015 • 2,000 licensed pharmacies • 8M prescription records (CS II-V)
  22. 22. Are all dispensers reporting? • Honor System – Unmet Expectations • Unique Pharmacy Identifier – Pharmacy DEA# • Match with MN pharmacy license # • Monthly Compliance – 1st notice – 2nd notice ($10,000 fine) – Phone Call – Complaint filed
  23. 23. How often are they reporting? • Daily reporting required – By procedure not statute • Inadequate Reporting – Definition • Less than 20 reports monthly • Identify manageable threshold – 10 reports – 18 reports
  24. 24. DATA QUALITY • Who uploads the data? – Pharmacy staff – Corporate office – External vendor • How are errors communicated and to whom? – Error reports • Email • Fax – Data uploader
  25. 25. Errors impacting end user • Minor – Days supply invalid (>180 days) – Refill code is not a # • Serious – Invalid prescriber DEA# – Invalid NDC # • Fatal – Blank prescriber DEA# – Blank DOB
  26. 26. Current initiative • Blast communication-2 months in advance – Uploader and PIC • Error correction within 7 days receipt of edit report • Establish relationship with data uploader • Auditing Begins – Weekly error summary report • Identify worst offenders – Errors that impact end user • Allow 7 days to pass then audit for error resolution
  27. 27. Determining Compliance • Errors resolved within 7 days • Outstanding errors – Phone call to Pharmacist in Charge (PIC) • Secure email with prescription details • Ongoing collaboration with PIC, uploader and PMP vendor – Complaint filed with Board
  28. 28. Outcomes • Compliance in reporting improved • Frequency of reporting improved • Improvement in data quality • Relationships improved
  29. 29. Lessons Learned • Communication is Critical – PMP and Dispenser – Dispenser and their Vendor • Start Out Small • Hidden Issues uncovered • Dedicated Resources • Work in Progress
  30. 30. Next Steps • Recognize “gold star” performance • Update contact lists • Update error report communication preference • Create tutorials-how to’s for data providers • Increase frequency of communications • Educate, educate, educate
  31. 31. THANK YOU
  32. 32. New Developments in PDMPs California’s CURES 2.0
  33. 33. Mike Small has disclosed no relevant, real or apparent personal or professional financial relationships with proprietary entities that produce health care goods and services. Artin Armagan has disclosed that his spouse is employed as a pharmacist by Duke Raleigh Hospital and Walmart Pharmacy.
  34. 34. New Developments in PDMPs California’s CURES 2.0 Learning Objective: Identify the features and benefits of California’s upgraded PDMP, CURES 2.0.
  35. 35. California Health and Safety Code section § 11165. (a) To assist health care practitioners in their efforts to ensure appropriate prescribing, ordering, administering, furnishing, and dispensing of controlled substances, law enforcement and regulatory agencies in their efforts to control the diversion and resultant abuse of Schedule II, Schedule III, and Schedule IV controlled substances, and for statistical analysis, education, and research, the Department of Justice shall . . . maintain the Controlled Substance Utilization Review and Evaluation System (CURES)…Review and Evaluation System (CURES)…
  36. 36. The Iatrogenically Addicted Patient and the Doctor Shopper ~ Information Delivery ~ Support the Public Health Sector ~ The Public Needs to Know ~ Analytics
  37. 37. Automated Registration California clinical users are provided a fully automated registration process. Delegation Authority Prescribers and dispensers can easily assign delegates who can initiate CURES 2.0 patient inquiries on their behalf. Compact Flagging Prescribers can easily notate their patients with treatment exclusivity compacts, forewarning other providers that additional prescribing to these patients can be potentially counter- productive to their existing treatment regimen. CURES 2.0 User Features
  38. 38. Peer-to-Peer Communication Prescribers and dispensers can instigate alert messages to fellow doctors and pharmacists about mutual patients of concern. Patient Safety Messaging Prescribers are alerted daily with information regarding their patients who reach various prescribing thresholds. CURES 2.0 User Features
  39. 39. CURES 2.0 systematically de-duplicates and de-identifies county and statewide data sets for County Health Officers and researchers. Quarterly and annual de-identified data sets are produced for County Health Officers. This data enables counties to calculate current rates of prescriptions, examine variations within the state, and track the impact of safe prescribing initiatives. De-Duplicated / De-Identified Data
  40. 40. 1. For Each Individual Prescriber, a List of That Prescriber's Rx Recipients Who are Currently Prescribed More than 100 Morphine Milligram Equivalency Per Day 2. For Each Individual Prescriber, a List of That Prescriber's Rx Recipients Who Have Obtained Prescriptions from 6 or More Prescribers or 6 or More Pharmacies During Last 6 Months 3. For Each Individual Prescriber, a List of That Prescriber's Rx Recipients Who Are Currently Prescribed More than 40 MMEs Methadone Daily 4. For Each Individual Prescriber, a List of That Prescriber's Rx Recipients Who Are Currently Prescribed Opioids More Than 90 Consecutive Days 5. For Each Individual Prescriber, a List of That Prescriber's Rx Recipients Who Are Currently Prescribed Both Benzodiazepines and Opioids Patient Safety Messaging
  41. 41. 1 Total Number of Prescriptions for Opioid Drugs by Month, by State, County and Zip Code 2 Total Number of Prescriptions for Opioid Drugs by Calendar Year, by State, County and Zip Code 3 Total Number of Unique Patients Prescribed Opioids by Month, by State, County and Zip Code 4 Total Number of Unique Patients Prescribed Opioids by Calendar Year, by State, County and Zip Code 5 Number of Opioid Pills Prescribed by Month, by State, County and Zip Code 6 Number of Opioid Pills Prescribed by Calendar Year, by State, County and Zip Code 7 Median Number of Opioid Pills Per Prescription by Month, by State, County and Zip Code Public Reports
  42. 42. 8 Median Number of Opioid Pills Per Prescribed by Calendar Year, by State, County and Zip Code 9 Number of Patients Receiving Opioid Prescriptions by Month, by State, County and Zip Code, by Age as Follows: ≤ 14; 15-24; 25-44; 45-64; ≥65 10 Number of Patients Receiving Opioid Prescriptions by Calendar Year, by State, County and Zip Code, by Age as Follows: ≤ 14; 15-24; 25-44; 45-64; ≥65 11 Number of Opioid Pills and Benzodiasepine Pills Prescribed to the Same Patient by Month, by State, County and Zip Code 12 Number of Opioid Pills and Benzodiasepine Pills Prescribed to the Same Patient by Calendar Year, by State, County and Zip Code Public Reports
  43. 43. 13 Number of Patients, by Month, Prescribed Both Opioids and Benzodiasepine, by State, County and Zip Code 14 Number of Patients, by Year, Prescribed Both Opioids and Benzodiasepine Within Any 30 Day Window, by State, County and Zip Code 15 Total Morphine Milligram and Morphine Kilogram Equivalents Prescribed by Month, by State, County and Zip Code 16 Total Morphine Milligram and Morphine Kilogram Equivalents Prescribed by Calendar Year, by State, County and Zip Code 17 Morphine Milligram and Morphine Kilogram Equivalents Prescribed by Month, by State, County and Zip Code for: Oxycodone, Hydrocodone, Morphine, Methadone, Hydromorphone, Buprenorphine, Fentanyl, Oxymorphone, Codeine, Levorphanol, and Zohydro Public Reports
  44. 44. 18 Morphine Milligram and Morphine Kilogram Equivalents Prescribed by Calendar Year, by State, County and Zip Code for: Oxycodone, Hydrocodone, Morphine, Methadone, Hydromorphone, Buprenorphine, Fentanyl, Oxymorphone, Codeine, Levorphanol, and Zohydro 19 Number of Very Frequent Opioid Prescribers (580+ Opioid Rx/Yr), Frequent Prescribers (50-579 Opioid Rx/Yr), Occasional Prescribers (8-49 Opioid Rx/Yr), and Rare Prescribers (1-7 Opioid Rx/Yr), by State, by State, County and Zip Code 20 Number of Very Frequent Schedule II Drug Prescribers (580+ Sked II Rx/Yr), Frequent Prescribers (50-579 Sked II Rx/Yr), Occasional Prescribers (8-49 Sked II Rx/Yr), and Rare Prescribers (1-7 Sked II Rx/Yr), by State, County and Zip Code 21 Total Number of Prescriptions for all Schedule II Drugs by Month, by State, County and Zip Code Public Reports
  45. 45. 21 Total Number of Prescriptions for all Schedule II Drugs by Month, by State, County and Zip Code 22 Total Number of Prescriptions for all Schedule II Drugs by Calendar Year, by State, County and Zip Code 23 Total Number of Prescriptions for Schedules II, III, and IV Drugs, by Schedule and Total, by Month, by State, County and Zip Code 24 Total Number of Prescriptions for Schedules II, III, and IV Drugs, by Schedule and Total, by Calendar Year, by State, County and Zip Code 25 Total Number Patients Receiving Schedule II, III and IV Drug Prescriptions, by Month, by State, County and Zip Code 26 Total Number Patients Receiving Schedule II, III and IV Drug Prescriptions, by Calendar Year, by State, County and Zip Code Public Reports
  46. 46. 27 Median Number of Pills Per Prescription for Schedules II, III, and IV Drugs by Month, by State, County and Zip Code 28 Median Number of Pills Prescribed for Schedules II, III, and IV Drugs by Calendar Year, by State, County and Zip Code 29 Median Number of Pills Per Prescription for Schedule II Drugs by Month, by State, County and Zip Code 30 Median Number of Pills Prescribed for Schedule II Drugs by Calendar Year, by State, County and Zip Code 31 Median Pills , by Month, Per Schedule II, III, or IV Prescription by Age as follows: ≤ 14; 15-24; 25-44; 45-64; ≥65 32 Median Pills , by Year, Per Schedule II, III, or IV Prescription by Age as follows: ≤ 14; 15-24; 25-44; 45-64; ≥65 Public Reports
  47. 47. 33 Number of Prescriber and Dispenser Registrants, by Month, by State, County and Zip Code 34 Number of Prescriber and Dispenser Registrants, by Year, by State, County and Zip Code 35 Number of Patients Who Obtained 4 or More Schedule II, III, or IV Prescriptions from 4 or More Dispensers During Prior 12 months, by State, County and Zip Code 36 Number of Patients Who Obtained 4 or More Schedule II, III, or IV Prescriptions from 4 or More Dispensers During the Calendar Year, by State, County and Zip Code 37 Number of Patients with Same Prescription Drug from 3 or More Prescribers, by Month, by State, County and Zip Code Public Reports
  48. 48. 38 Number of Patients with Same Prescription Drug from 3 or More Prescribers, by Calendar Year, by State, County and Zip Code 39 Number of CURES Inquiries by Prescribers, by Month, by State, County, and Zip Code 40 Number of CURES Inquiries by Prescribers, by Year, by State, County, and Zip Code 41 Number of CURES Inquiries by Dispensers, by Month, by State, County, and Zip Code 42 Number of CURES Inquiries by Dispensers, by Year, by State, County, and Zip Code 43 Numbers of Prescribers Prescribing Opioids and Benzodiazepines Concurrently to a Patient, by Month, by State, County, and Zip Code Public Reports
  49. 49. 44 Numbers of Prescribers Prescribing Opioids and Benzodiazepines Concurrently to a Patient, by Year, by State, County, and Zip Code 45 Number of Patients Currently Prescribed More than 100 Morphine Milligram Equivalency Per Day, by Month, by State, County, and Zip Code 46 Number of Patients Currently Prescribed More than 100 Morphine Milligram Equivalency Per Day, by Year, by State, County, and Zip Code 47 Number of Patients Who Are Currently Prescribed More than 40 Milligrams Methadone Daily, by Month, by State, County, and Zip Code 48 Number of Patients Who Are Currently Prescribed More than 40 Milligrams Methadone Daily, by Year, by State, County, and Zip Code Public Reports
  50. 50. ASAP DATABASE ENTITY RESOLUTION ANOMALY DETECTION DE- IDENTIFIED DATA REPORTING ALERT GENERATION
  51. 51. ENTITY RESOLUTION John Doe 01/01/70 456 HARRISON AVE CARY, NC 27513John Doe 01/01/70 123 HARRISON AVE CARY, NC 27513 John Doe 01/01/70 789 HARRISON AVE CARY, NC 27511 Johnnie Doe 01/01/70 123 HARISON AVE CARY, NC 27511 ONE ENTITY
  52. 52. PATIENT SCENARIOS 1. Rx Recipients Who are Currently Prescribed More than 100 Morphine Milligram Equivalency Per Day 2. Rx Recipients Who Have Obtained Prescriptions from 6 or More Prescribers or 6 or More Pharmacies During Last 6 Months 3. Rx Recipients Who Are Currently Prescribed More than 40 MMEs Methadone Daily 4. Rx Recipients Who Are Currently Prescribed Opioids More Than 90 Consecutive Days 5. Rx Recipients Who Are Currently Prescribed Both Benzodiazepines and Opioids
  53. 53. ENTITY RESOLUTION & SCENARIOS
  54. 54. TIME 30 MME80 MME110 MME110 MME + BENZO OPIOID OPIOID OPIOID BENZO
  55. 55. ALERTS • Patient Name • Patient DOB • Patient Address • Patient City • Patient Zip Code • # of Anomalous Scenarios • Triggered Scenarios
  56. 56. DE-IDENTIFIED DATA  Anonymized Patient ID  Anonymized Prescriber ID  Anonymized Pharmacy ID  Patient Birth Year  Patient Gender  Patient Zip Code  Patient County  Patient State  Prescriber Zip Code  Prescriber County  Prescriber State  Pharmacy Zip Code  Pharmacy County  Pharmacy State  Product Name  NDC  Drug Form  Strength  Quantity  Days Supply  Date Filled  Refill Number  Payment Code  Prescriber Specialty  Prescriber Board Certification Indicator • Personally identifying information redacted. • Anonymized patient IDs maintained to be consistent from report to report. • Generated quarterly and annually for each county and the entire state.
  57. 57. Questions? Thank You!
  58. 58. New Developments in PDMPs: California, Colorado and Minnesota Presenters: • Mark R. O’Neill, RPh, Program Manager, Colorado Prescription Drug Monitoring Program • Barbara A. Carter, PMP Manager, Minnesota Board of Pharmacy, Prescription Monitoring Program • Tina Farales, Department of Justice Administrator, Prescription Drug Monitoring Program, California Department of Justice • Artin Armagan, PhD, Manager, Advanced Analytics Lab, SAS Institute PDMP Track Moderator: John L. Eadie, Coordinator, Public Health and Prescription Drug Monitoring Program Project, National Emerging Threat Initiative, National HIDTA Assistance Center, and Member, Rx and Heroin Summit National Advisory Board

×